BFEC
ATHN

Benjamin F. Edwards & Company’s Athenahealth, Inc. ATHN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-150
Closed -$20K – 1814
2018
Q4 		$20K Hold
150
– – ﹤0.01% 1097
2018
Q3 		$20K Sell
150
-125
-45% -$18.7K ﹤0.01% 1118
2018
Q2 		$44K Hold
275
– – ﹤0.01% 889
2018
Q1 		$39K Hold
275
– – ﹤0.01% 906
2017
Q4 		$37K Buy
275
+10
+4% +$1.28K ﹤0.01% 872
2017
Q3 		$33K Buy
265
+150
+130% +$20.7K ﹤0.01% 865
2017
Q2 		$16K Buy
+115
New +$14.4K ﹤0.01% 958
2016
Q2 		– Sell
-40
Closed -$6K – 1152
2016
Q1 		$6K Hold
40
– – ﹤0.01% 907
2015
Q4 		$6K Sell
40
-41
-51% -$6.33K ﹤0.01% 957
2015
Q3 		$11K Hold
81
– – ﹤0.01% 860
2015
Q2 		$9K Hold
81
– – ﹤0.01% 961
2015
Q1 		$10K Buy
+81
New +$10.8K ﹤0.01% 906

Benjamin F. Edwards & Company's ATHN Position: Q1 2019 in Review

Benjamin F. Edwards & Company sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 150 shares — an estimated $20K sold.

Benjamin F. Edwards & Company first reported a position in ATHN in Q1 2015 and held it in 12 quarters. The position peaked at $44K in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Benjamin F. Edwards & Company reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 150 Athenahealth, Inc. shares in Q1 2019, an estimated $20K.
  • Benjamin F. Edwards & Company first reported a position in Athenahealth, Inc. in Q1 2015 and held it in 12 quarters.
  • Benjamin F. Edwards & Company's Athenahealth, Inc. position peaked at $44K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2019, filed 15 May 2019.